Laboratorios Farmacéuticos ROVI, S.A. S.A. is a fully-integrated, profitable, Spanish specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of small molecule and specialty biologic drugs.

Laboratorios Farmacéuticos ROVI, S.A. in line with its commitment to transparency and informative rigour presents this web section addressed to shareholders and investors, with the purpose to make available all information required by the ministerial decree ECC/461/2013 of March 20 and the Circular 3/2015 of June 23 of the CNMV, as well as all information available that the company will consider relevant about Corporate Governance's practices.


DateTitleContent
26/04/2017Convocatorias y Acuerdos de Juntas y Asambleas GeneralesROVI informs about the call for the 2017 Ordinary General Shareholders Meeting
21/04/2017Información sobre resultadosROVI releases the presentation related to the 2017 first quarter results
21/04/2017Información sobre resultadosROVI releases the presentation related to the 2017 first quarter results
06/04/2017Contratos de liquidez y contrapartidaLiquidity contract: transactions conducted in the first quarter of 2017
13/03/2017Otros sobre negocio y situación financieraThe Company releases the presentation related to its biosimilar of Enoxaparin